Financials
Financial year 2025
LE VINH PHARMA from Wavre, company number BE0823663424, closed financial year 2025 with a result of € 9,124 after tax. For that financial year LE VINH PHARMA recorded a gross margin of € 9,612 and equity of € 21,026. Compared with financial year 2024, the result moved from € 5,812 to € 9,124. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.
€ 21,026
▲ 77% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,124
▲ 57% vs 2024
Profit after tax over the fiscal year.
€ 11,637
▲ 174% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2,426.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 662
▲ € 570 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,297
▼ 40% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 815
▲ 262% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 7,925 | € 6,111 | € 8,046 | € 9,612 | ▲ 19% |
| Profit after taxes | € 305 | € -1,515 | € 5,812 | € 9,124 | ▲ 57% |
| Equity | € 7,605 | € 6,090 | € 11,902 | € 21,026 | ▲ 77% |
| Total debts | € 6,830 | € 2,519 | € 4,070 | € 3,112 | ▼ 24% |
| Cash | € 1,995 | € 4,065 | € 4,251 | € 11,637 | ▲ 174% |
| Retained profit | € -10,995 | € -12,510 | € -6,698 | € 2,426 | ▲ € 9,124 |
| Balance sheet total | € 14,436 | € 8,610 | € 15,973 | € 24,139 | ▲ 51% |
Key figures of LE VINH PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LE VINH PHARMA?
What happened at LE VINH PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,124 (▲ 57% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Ukkel. KBO
In short
From € 305 profit in 2022 to € 9,124 profit in 2025.
Paid € 465 in corporate taxes since 2022.
Best year ever: 2025, with € 9,124 profit.
Management
Behind LE VINH PHARMA is Thao Le Vinh.
Directors
According to the 2025 annual accounts
Thao Le Vinh
Administrator-manager
Establishments
Establishment units
Physical locations of this company
Avenue Duc Henri de Brabant 25
1300 Wavre
Jean Benaetsstraat 71
1180 Ukkel
Active since 26 February 2010
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- LE Vinh Thao(oprichter) 99%
- NGUYEN Thi Tou(oprichter) 1%
Details
- Company number
- 0823.663.424
- VAT number
- BE 0823.663.424
- Registered office
- Avenue Duc Henri de Brabant 25, 1300 Wavre
- Names & denominations
- LE VINH PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 March 2010
- Peppol
- Active · Active since 5 Jan 2026
- Activities · NACE
Handelsbemiddeling in de niet-gespecialiseerde groothandel
Groothandel in farmaceutische en medische artikelen